Dermapharm Holding SE (DMPHF)

PNK: DMPHF · Real-Time Price · USD

39.56

0.00 (0.00%)

At close: Apr 25, 2025, 9:30 AM

Dermapharm SE Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016
Revenue	1.19B	1.17B	1.14B	1.12B	1.14B	1.16B	1.14B	1.11B	1.02B	1.01B	986.28M	962.34M	942.91M	886.85M	843.38M	813.57M	793.83M	760.48M	745.9M	729.8M	700.88M	661.04M	625.34M	598.48M	572.42M	546.39M	513.15M	486.54M	467.12M	474.95M	359.48M	243.33M	125.26M
Cost of Revenue	420.43M	436.65M	430.86M	432.03M	436.55M	414.53M	404.96M	385.66M	363.94M	358.42M	344M	328.44M	322.22M	319.58M	317.27M	322.95M	330.35M	326.46M	330.25M	330.98M	317.16M	301.19M	287.75M	281.04M	272.66M	267.06M	257.1M	247.92M	245.64M	258.98M	195.47M	133.15M	71.43M
Gross Profit	767.07M	734.32M	712.97M	690.97M	704.14M	742.54M	730.78M	726.59M	660.83M	648.55M	642.28M	633.9M	620.7M	567.27M	526.11M	490.62M	463.48M	434.01M	415.66M	398.82M	383.72M	359.85M	337.59M	317.44M	299.76M	279.33M	256.05M	238.62M	221.47M	215.97M	164.01M	110.18M	53.83M
Operating Income	216.93M	206.09M	191.13M	164.29M	182.89M	222.7M	247.36M	269.9M	243.69M	268.25M	277.46M	304.78M	298.47M	234.56M	184.06M	148.91M	136.85M	131.88M	127.09M	130.47M	119.51M	112.29M	110.8M	105.86M	107.51M	103.91M	99.15M	97.38M	92.11M	92.18M	68.67M	46.89M	21.74M
Interest Income	20.85M	23.49M	19.14M	20.82M	7.82M	7.82M	6.99M	566K	1.23M	2.58M	2.7M	5.1M	4.12M	2.83M	2.71M	349K	534K	472K	2.26M	4.39M	4.21M	4.21M	2.85M	2.5M	2.72M	2.72M	2.88M	3.31M	3.28M	3.28M	2.6M	312K	n/a
Pretax Income	172M	141.76M	129.77M	100.07M	106M	158.45M	196M	228.69M	216.3M	261.15M	271.42M	301.36M	292.98M	226.36M	175.35M	137.51M	125.28M	117.74M	113.8M	119.64M	110.07M	106.89M	106.68M	101.6M	104.24M	100.83M	96.04M	93.7M	88.03M	88.19M	65.52M	45.22M	21.04M
Net Income	113.79M	90.58M	83.04M	56.58M	62.37M	94.95M	122.56M	146.27M	134.24M	175.99M	185.34M	210.64M	209.58M	162.48M	123.32M	95.47M	85.83M	80.01M	76.61M	84.7M	77.2M	73.49M	76.55M	73.09M	75.32M	121.62M	107.31M	95.49M	94.4M	39.11M	31.1M	26.31M	6.02M
Selling & General & Admin	73.88M	148.24M	189.81M	140.98M	190.54M	144.42M	136M	141.78M	92.22M	63.98M	30.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research & Development	n/a	19.89M	19.89M	19.89M	19.89M	20.87M	20.87M	20.87M	20.87M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	476.26M	360.11M	237.41M	172.93M	49.72M	29.55M	26.49M	27.08M	16.77M	7.77M	3.3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	550.14M	446.48M	440.1M	444.93M	439.5M	521.48M	485.06M	458.33M	418.79M	391.73M	376.25M	340.55M	333.65M	324.29M	333.64M	333.3M	318.21M	301.91M	288.34M	268.11M	263.98M	246.2M	225.43M	210.23M	190.9M	176.71M	158.2M	142.54M	130.66M	124.48M	96.04M	63.98M	32.78M
Interest Expense	60.38M	64.68M	65.74M	64.37M	62.51M	51.67M	35.89M	24.41M	13.24M	9.56M	9.48M	9.47M	9.47M	9.58M	9.49M	9.66M	9.94M	10.73M	11.86M	12.56M	11.93M	9.72M	7.3M	6.99M	6.17M	6.17M	6.4M	7.43M	7.81M	9.49M	7.55M	3.34M	1.68M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	967.83M	962.15M	949.97M	955.98M	957.8M	936.01M	890.02M	843.99M	782.73M	750.15M	720.24M	668.99M	655.87M	643.87M	650.91M	656.25M	648.56M	628.37M	618.59M	599.09M	581.13M	547.4M	513.18M	491.27M	463.56M	443.77M	415.3M	390.46M	376.3M	383.46M	291.51M	197.13M	104.22M
Income Tax Expense	60.27M	52.44M	48.93M	45.55M	45.46M	65.45M	75.37M	84.11M	83.68M	86.22M	86.71M	91.56M	84.07M	64.59M	52.71M	42.16M	39.36M	37.01M	36.3M	34.23M	32.25M	33.08M	30.05M	28.54M	29.01M	25.8M	19.82M	14.86M	10.29M	4.2M	4.87M	3.8M	-97K
Shares Outstanding (Basic)	53.96M	n/a	53.96M	53.85M	54.05M	53.84M	53.84M	53.84M	53.84M	53.25M	53.77M	53.84M	53.72M	53.66M	53.81M	53.84M	54.08M	53.96M	54.41M	53.33M	54.44M	53.48M	52.79M	53.21M	53.58M	54.57M	53.56M	52.16M	50.1M	50.1M	12.28M	49.49M	50.1M
Shares Outstanding (Diluted)	53.96M	n/a	53.96M	53.85M	54.05M	53.84M	53.84M	53.84M	53.84M	53.25M	53.77M	54.16M	53.72M	53.66M	53.81M	54.2M	54.08M	53.96M	54.41M	53.33M	54.44M	53.48M	52.79M	53.21M	53.58M	54.57M	53.56M	52.16M	53.84M	53.84M	12.28M	49.49M	53.84M
EPS (Basic)	1.51	1.08	1.54	1.05	1.16	1.77	2.29	2.73	2.50	3.27	3.44	3.91	3.89	3.01	2.28	1.76	1.59	1.48	1.42	1.58	1.44	1.38	1.43	1.36	1.41	1.43	2.11	2.19	2.19	3.21	2.12	1.73	1.32
EPS (Diluted)	1.51	1.08	1.54	1.05	1.16	1.77	2.29	2.73	2.50	3.27	3.44	3.91	3.89	3.01	2.28	1.76	1.59	1.48	1.42	1.58	1.44	1.38	1.43	1.36	1.41	1.41	2.01	2.09	2.09	3.04	2.03	1.64	1.23
EBITDA	300.8M	294.51M	283.57M	262.99M	275.05M	306.54M	321.39M	347.23M	330.57M	355.83M	352.04M	349.05M	339.53M	268.69M	229.24M	197.29M	183.83M	174.85M	173.31M	174.17M	165.54M	159.32M	150.71M	142.44M	135.77M	124.68M	117.67M	112.77M	106.3M	106.86M	77.91M	53.8M	26.11M
EBIT	218.58M	187.94M	177.02M	159.74M	163.81M	209.98M	231.75M	252.95M	229.39M	270.7M	280.9M	310.83M	302.45M	235.94M	184.84M	147.63M	135.67M	128.2M	125.38M	131.47M	121.27M	116.48M	113.84M	108.46M	110.27M	106.37M	101.81M	100.51M	95.21M	96.92M	72.31M	47.8M	21.95M
Depreciation & Amortization	86.78M	69.08M	69.06M	80.47M	75.92M	98.91M	92.26M	97.47M	94.91M	84.73M	83.67M	56.41M	55.16M	50.26M	49.2M	48.85M	47.42M	46.11M	46.93M	46.65M	47.88M	46.99M	40.63M	36.75M	30.33M	22.81M	20.82M	17.12M	15.86M	14.69M	10.65M	7.23M	3.82M